Results 181 to 190 of about 47,712 (207)
Some of the next articles are maybe not open access.
The safety and tolerability of GLP‐1 receptor agonists in the treatment of type 2 diabetes: a review
Diabetes/Metabolism Research and Reviews, 2011Vanita R Aroda, Robert Ratner
exaly
Tolerance develops toward GLP-1 receptor agonists’ glucose-lowering effect in mice
European Journal of Pharmacology, 2020Kertu Rünkorg +2 more
exaly
Coprescribing GLP-1 Receptor Agonists and Lifestyle
JAMA Internal MedicineMichelle S, Rockwell +2 more
openaire +2 more sources
Cardiovascular safety and benefits of GLP-1 receptor agonists
Expert Opinion on Drug Safety, 2017Andreas Brønden +2 more
exaly
GLP-1 receptor agonists and obesity care
BMJJuan V A, Franco, Jen, Manne-Goehler
openaire +2 more sources
Side effects of GLP-1 receptor agonists
BMJJennifer, Manne-Goehler, Juan, Franco
openaire +2 more sources
Fair Allocation of GLP-1 and Dual GLP-1–GIP Receptor Agonists
New England Journal of MedicineGovind, Persad +2 more
openaire +6 more sources
Physician perceptions of GLP-1 receptor agonists in the UK
Current Medical Research and Opinion, 2016Louis S Matza +2 more
exaly